A significant downregulation in catalase activity levels was observed in RBCs from patients with AMD (0.33 ± 0.21 U/mg Hb) compared to controls (0.53 ± 0.24; p < 0.0001). The gene discussed is GSTM1; the disease is age-related macular degeneration.